LCN2 and acute kidney injury: New biomarkers have been identified in the past few years, including cystatin-C, neutrophil gelatinase-associated lipocalin (NGAL), and interleukin (IL)-18; however, these markers are not sensitive enough to diagnose AKI in the intensive care unit [6].